Home> Regulatory Information

Announcement of NMPA on Revising the Package Inserts of Drugs Containing Pipemidic Acid

CCFDIE| Updated: 2020-01-21

To further protect drug safety for the people, on January 21, 2020, NMPA issued an announcement with decisions made to revise the [adverse reactions], [precautions] and other Entries on the package inserts of drugs containing pipemidic acid (including pipemidic acid tablets, capsules, and granules).